Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of locally advanced non‐small cell lung cancer: State of the art and future directions
Da Miao, Jing Zhao, Ying Han, et al.
Cancer Communications (2023) Vol. 44, Iss. 1, pp. 23-46
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Disturbing Cholesterol/Sphingolipid Metabolism by Squalene Epoxidase Arises Crizotinib Hepatotoxicity
Hao Yan, Xiangliang Huang, Yourong Zhou, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
CircKIAA0182 Enhances Lung Cancer Progression and Chemoresistance through Interaction with YBX1
Masha Huang, Jingyi Sun, Qingqing Jiang, et al.
Cancer Letters (2025) Vol. 612, pp. 217494-217494
Closed Access | Times Cited: 1
Berberine restrains non-small cell lung cancer cell growth, invasion and glycolysis via inactivating the SPC25/NUF2 pathway
Meng Lv, Xiangrui Chen, Qinbo Yang, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Comparison of Al[18F]-NOTA-FAPI-04 PET/CT and [18F]-FDG PET/CT in a patient with lung cancer and pulmonary tuberculosis: a case report and literature review
Jingjie Qin, Jinming Yu, Yuchun Wei
Frontiers in Oncology (2025) Vol. 15
Open Access
Systemic Immune-Inflammation Index as a Predictor of Survival in Non-Small Cell Lung Cancer Patients Undergoing Immune Checkpoint Inhibition: A Systematic Review and Meta-Analysis
Ye Zhang, Yeye Chen, Chao Guo, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104669-104669
Closed Access
Primary tumour resection in non-small cell lung cancer patients with pleural dissemination unexpectedly detected during operation: a two-centre retrospective cohort study
Tao Bao, Yuanlin Deng, Liang Chen, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Concurrent chemoradiotherapy plus immunotherapy for locally advanced non-small-cell lung cancer: clinical efficacy and prognostic analysis
Xiangning Lan, Xiaoyu Zhou, Kejun Dai, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 1311-1320
Closed Access
Glycyrrhizin enhances the antitumor activity of cisplatin in non‑small cell lung cancer cells by influencing DNA damage and apoptosis
Zhufeng Tong, Zhen Wang, Jinghan Jiang, et al.
Oncology Letters (2025) Vol. 29, Iss. 4, pp. 1-10
Open Access
Research Progress on Factors of Immunotherapy Resistance in Non-Small Cell Lung Cancer
峰 赵
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 846-852
Closed Access
Integration of intratumoral and peritumoral CT radiomic features with machine learning algorithms for predicting induction therapy response in locally advanced non-small cell lung cancer
Feng Cai, Zhengjun Guo, Guoyu Wang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Efficacy and safety of induction immunochemotherapy followed by radiotherapy for patients with unresectable locally advanced non-small cell lung cancer: A retrospective study
Liu Li-pin, Cui Gao, Yimin Yang, et al.
Radiation Oncology (2025) Vol. 20, Iss. 1
Open Access
Tumor treating fields enhance anti-PD therapy by improving CCL2/8 and CXCL9/CXCL10 expression through inducing immunogenic cell death in NSCLC models
Wei Lin, Yingying Wang, Minghao Li, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
NAT10 promotes radiotherapy resistance in non-small cell lung cancer by regulating KPNB1-mediated PD-L1 nuclear translocation
Dagao Zhu, Mingliang Lu, Haiying Cheng
Open Life Sciences (2025) Vol. 20, Iss. 1
Open Access
Development of an alkaliptosis-related lncRNA risk model and immunotherapy target analysis in lung adenocarcinoma
Xiang Xiong, Wenzhao Liu, Chun‐Hsu Yao
Frontiers in Genetics (2025) Vol. 16
Open Access
Raddeanin A exerts potent efficacy against non-small cell lung cancer by inhibiting cyclin-dependent kinase 6
Xian Wang, Xiao Lin, Yuxin Liu, et al.
Translational Oncology (2025) Vol. 56, pp. 102382-102382
Closed Access
RAF1 promotes anlotinib resistance in non-small cell lung cancer by inhibiting apoptosis
Shuo Wu, Chenxi Hu, Ping Hu, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 4
Open Access
MYCN/MNX1 Axis Drives NSCLC Progression by Inducing Macrophage M2 Polarization and CD8+ T Cell Apoptosis via the Wnt/β‐Catenin Pathway
Chengzhang Cao, Hong-Toan Lai, Shi Yu-zhen
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 4
Closed Access
Parabacteroides distasonis promotes CXCL9 secretion of tumor-associated macrophages and enhances CD8+T cell activity to trigger anti-tumor immunity against anti-PD-1 treatment in non-small cell lung cancer mice
Zhijun Fan, Yi Zheng, Sheng Li, et al.
BMC Biotechnology (2025) Vol. 25, Iss. 1
Open Access
Engineered lung cell targeting and SLC7A11 siRNA expressing bacterial extracellular vesicles impair the progression of none‐small cell lung cancer
Xiaodan Wan, Xueliang Zhou, Jinlong Liu, et al.
Bioengineering & Translational Medicine (2025)
Open Access
CKS1B regulates the radiosensitivity of lung cancer via activating the PI3K/AKT signaling pathway
Jiangyue Lu, Lehui Du, Pei Zhang, et al.
Cellular Signalling (2025), pp. 111828-111828
Closed Access
A novel tRNA-Derived Fragment, tRF-20-M0NK5Y93 inhibits the malignant progression of non-small cell lung cancer by mediating PLOD1
Lixin Wu, Xiaojie Chen, Chen Dong, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110431-110431
Closed Access
Adverse events associated with immune checkpoint inhibitors in non-small cell lung cancer: a safety analysis of clinical trials and FDA pharmacovigilance system
Xueyan Liang, Hewei Xiao, Huijuan Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
LncRNA PGM5-AS1 inhibits non-small cell lung cancer progression by targeting miRNA-423-5p/SLIT2 axis
Jiajun Wang, Jun Ye, Yuxue Dang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Targeted delivery of the metastasis-specific tumour homing TMTP1 peptide to non-small-cell lung cancer (NSCLC) using inhalable hybrid nano-assemblies
Eupa Ray, Krishna Jadhav, Monika Kadian, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 38, pp. 9740-9759
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top